• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用日本基因组数据库比较血管性血友病因子基因变异的基因型和表型

Comparison of genotypes and phenotypes for von Willebrand factor gene variants using Japanese genome database.

作者信息

Akimoto Takafumi, Inaba Hiroshi, Ogishima Soichi, Kumada Kazuki, Mitsuhashi Ayano, Miyashita Ryui, Yamaguchi Tomoko, Bingo Masato, Chikasawa Yushi, Shinozawa Keiko, Hagiwara Takeshi, Amano Kagehiro, Kodama Eiichi N, Kinai Ei

机构信息

Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.

Department of Informatics for Genomic Medicine, Group of Integrated Database Systems, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

出版信息

Blood Vessel Thromb Hemost. 2025 Apr 10;2(3):100070. doi: 10.1016/j.bvth.2025.100070. eCollection 2025 Aug.

DOI:10.1016/j.bvth.2025.100070
PMID:40765908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12320396/
Abstract

von Willebrand disease (VWD) is a common inherited bleeding disorder. The aim of this study was to determine the predicted disease states associated with various pathogenic von Willebrand factor (VWF) variants and their phenotypes using the largest Japanese whole-genome database. Of the 5857 gene variants registered in the Japanese Multi-Omics Reference Panel (jMorp), variants with the following criteria were extracted: (1) caused protein abnormalities due to genetic alterations; (2) have already been detected and included in a database, including known association with VWD; and (3) highly likely pathogenic by in silico analysis. We measured VWF activity, antigen, propeptide, and collagen binding activity in stored plasma samples obtained from heterozygous carriers of the selected variants. A total of 29 variants (26 single nucleotide and 3 small insertions/deletions) were detected, and 6 of these were found in Leiden Open Mutation Database. We obtained 43 plasma samples from individuals carrying these 29 variants as heterozygous. For the 43 variant carriers, their mean age was 43.0 years, and blood group was type O in 17 (39.5%). Analysis of these plasma samples showed low VWF levels (<50%) in 6 (14.0%). Low VWF levels were found in 2 of 8 of the nonsense (25%) and 4 of 31 of the missense variants (12.9%). Taking into consideration the limitation of using stored plasma samples, analysis of the jMorp indicated that most gene variants with predicted pathogenic potential did not correlate with phenotypic expression. Our results supported incomplete penetrance and variable expressivity of the gene variants.

摘要

血管性血友病(VWD)是一种常见的遗传性出血性疾病。本研究的目的是使用最大的日本全基因组数据库,确定与各种致病性血管性血友病因子(VWF)变异及其表型相关的预测疾病状态。在日本多组学参考面板(jMorp)中登记的5857个基因变异中,提取符合以下标准的变异:(1)因基因改变导致蛋白质异常;(2)已被检测到并包含在数据库中,包括与VWD的已知关联;(3)通过计算机分析极有可能致病。我们在从所选变异的杂合携带者获得的储存血浆样本中测量了VWF活性、抗原、前肽和胶原结合活性。共检测到29个变异(26个单核苷酸变异和3个小插入/缺失),其中6个在莱顿开放突变数据库中被发现。我们从携带这29个变异的杂合个体中获得了43份血浆样本。对于这43名变异携带者,他们的平均年龄为43.0岁,17人(39.5%)的血型为O型。对这些血浆样本的分析显示,6人(14.0%)的VWF水平较低(<50%)。在8个无义变异中的2个(25%)和31个错义变异中的4个(12.9%)中发现了低VWF水平。考虑到使用储存血浆样本的局限性,对jMorp的分析表明,大多数具有预测致病潜力的基因变异与表型表达无关。我们的结果支持了基因变异的不完全外显率和可变表达性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/a89064aaa184/BVTH_VTH-2024-000287-gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/5ea29f38a0bc/BVTH_VTH-2024-000287-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/c187bb8a43bf/BVTH_VTH-2024-000287-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/36f154e82375/BVTH_VTH-2024-000287-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/d02de110baf1/BVTH_VTH-2024-000287-gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/6cf2b45a8565/BVTH_VTH-2024-000287-gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/a89064aaa184/BVTH_VTH-2024-000287-gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/5ea29f38a0bc/BVTH_VTH-2024-000287-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/c187bb8a43bf/BVTH_VTH-2024-000287-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/36f154e82375/BVTH_VTH-2024-000287-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/d02de110baf1/BVTH_VTH-2024-000287-gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/6cf2b45a8565/BVTH_VTH-2024-000287-gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/12320396/a89064aaa184/BVTH_VTH-2024-000287-gr5.jpg

相似文献

1
Comparison of genotypes and phenotypes for von Willebrand factor gene variants using Japanese genome database.利用日本基因组数据库比较血管性血友病因子基因变异的基因型和表型
Blood Vessel Thromb Hemost. 2025 Apr 10;2(3):100070. doi: 10.1016/j.bvth.2025.100070. eCollection 2025 Aug.
2
Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding.血管性血友病因子抗原水平≤50 IU/dL的遗传学研究确定了与血管性血友病和出血风险增加相关的变异。
J Thromb Haemost. 2025 Aug;23(8):2410-2421. doi: 10.1016/j.jtha.2025.04.029. Epub 2025 May 12.
3
Clinical, Phenotypic and Genotypic Characteristics of Von Willebrand Disease in Afro-Caribbeans: Results From a Study in Martinique Island, French West Indies.非洲加勒比人群中血管性血友病的临床、表型和基因型特征:法属西印度群岛马提尼克岛的一项研究结果
Haemophilia. 2025 May;31(3):458-476. doi: 10.1111/hae.70003. Epub 2025 Mar 23.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
6
Probing rare von Willebrand disease-causing mutations in the D4 and C-domains of von Willebrand factor.探究血管性血友病因子D4和C结构域中罕见的导致血管性血友病的突变。
Res Pract Thromb Haemost. 2025 Jun 6;9(4):102922. doi: 10.1016/j.rpth.2025.102922. eCollection 2025 May.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Ratio of Von Willebrand Collagen Binding Assay and Von Willebrand Antigen Can Predict Multimer Size in Von Willebrand Disease.血管性血友病因子胶原结合试验与血管性血友病因子抗原的比值可预测血管性血友病的多聚体大小。
Haemophilia. 2025 May;31(3):450-457. doi: 10.1111/hae.70025. Epub 2025 Mar 7.
9
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.抗纤维蛋白溶解疗法用于预防血友病或血管性血友病患者在接受小型口腔手术或拔牙时的口腔出血。
Cochrane Database Syst Rev. 2015 Dec 24(12):CD011385. doi: 10.1002/14651858.CD011385.pub2.
10
A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants.1型血管性血友病的一种新病因:双等位基因MADD变异导致魏尔-帕拉德小体胞吐受损。
Blood. 2025 Jul 15. doi: 10.1182/blood.2024027935.

本文引用的文献

1
von Willebrand disease.血管性血友病。
Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8.
2
Application of genetic testing for the diagnosis of von Willebrand disease.遗传性血管性血友病(von Willebrand 病)的基因检测应用。
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.
3
jMorp: Japanese Multi-Omics Reference Panel update report 2023.jMorp:日本多组学参考面板 2023 年更新报告。
Nucleic Acids Res. 2024 Jan 5;52(D1):D622-D632. doi: 10.1093/nar/gkad978.
4
Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases.利用大规模基因数据库研究血管性血友病的人群患病率及突变图谱。
NPJ Genom Med. 2023 Oct 16;8(1):31. doi: 10.1038/s41525-023-00375-8.
5
Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources.新指南时代血管性血友病的实验室诊断:基于地理和资源的考量
Res Pract Thromb Haemost. 2023 Jun 30;7(5):102143. doi: 10.1016/j.rpth.2023.102143. eCollection 2023 Jul.
6
Genetic determinants of enhanced von Willebrand factor clearance from plasma.增强型 von Willebrand 因子从血浆中清除的遗传决定因素。
J Thromb Haemost. 2023 May;21(5):1112-1122. doi: 10.1016/j.jtha.2023.01.012. Epub 2023 Jan 20.
7
Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional Study.潜在可预防的血管性血友病患者的疾病负担:一项欧洲横断面研究的事后分析。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221130334. doi: 10.1177/10760296221130334.
8
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.不完全显性与可变表达:从临床研究到人群队列
Front Genet. 2022 Jul 25;13:920390. doi: 10.3389/fgene.2022.920390. eCollection 2022.
9
Variant interpretation using population databases: Lessons from gnomAD.使用人群数据库进行变异解释:来自 gnomAD 的经验。
Hum Mutat. 2022 Aug;43(8):1012-1030. doi: 10.1002/humu.24309. Epub 2021 Dec 16.
10
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.ASH ISTH NHF 2021 指南:关于血管性血友病的诊断。
Blood Adv. 2021 Jan 12;5(1):280-300. doi: 10.1182/bloodadvances.2020003265.